Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C22H24FN3OS |
| Molecular Weight | 397.509 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
FC1=CC=C(C=C1)C(=O)CCCN2CCC(CC2)N3C(=S)NC4=C3C=CC=C4
InChI
InChIKey=YDLQKLWVKKFPII-UHFFFAOYSA-N
InChI=1S/C22H24FN3OS/c23-17-9-7-16(8-10-17)21(27)6-3-13-25-14-11-18(12-15-25)26-20-5-2-1-4-19(20)24-22(26)28/h1-2,4-5,7-10,18H,3,6,11-15H2,(H,24,28)
| Molecular Formula | C22H24FN3OS |
| Molecular Weight | 397.509 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionSources: http://www.ncbi.nlm.nih.gov/pubmed/10215017Curator's Comment: description was created based on several sources, including:
https://medical.mt-pharma.co.jp/di/file/dc/tol_f.htm
https://www.medicallibrary-dsc.info/di/tolopelon_tablets_3mg/pdf/if_tp_tab_1301_09.pdf
Sources: http://www.ncbi.nlm.nih.gov/pubmed/10215017
Curator's Comment: description was created based on several sources, including:
https://medical.mt-pharma.co.jp/di/file/dc/tol_f.htm
https://www.medicallibrary-dsc.info/di/tolopelon_tablets_3mg/pdf/if_tp_tab_1301_09.pdf
Timiperone is a neuroleptic agent that was developed in Japan. Timiperone has a potent antipsychotic activity, which is comparable to other butyrophenones such as haloperidol (HAL). Timiperone has a five-eight-times higher affinity to dopamine receptors and a 15-times higher affinity to serotonin receptors than those of HAL. Clinical trials have suggested that TIM has a specific action against negative symptoms such as lack of initiative or blunted affect as well as positive symptoms such as delusions and hallucinations in schizophrenics.
CNS Activity
Originator
Sources: https://www.google.ch/patents/US3963727
Curator's Comment: Timiperone was created in 1973 by Daiichi Pharmaceutical Co., Ltd. (currently: Daiichi Sankyo Co., Ltd.).
Approval Year
Cmax
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
5.947 ng/mL |
6 mg single, oral dose: 6 mg route of administration: Oral experiment type: SINGLE co-administered: |
TIMIPERONE plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: UNKNOWN food status: FED |
|
13.6 ng/mL |
4 mg single, intramuscular dose: 4 mg route of administration: Intramuscular experiment type: SINGLE co-administered: |
TIMIPERONE plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: UNKNOWN food status: UNKNOWN |
AUC
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
39.321 ng × h/mL |
6 mg single, oral dose: 6 mg route of administration: Oral experiment type: SINGLE co-administered: |
TIMIPERONE plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: UNKNOWN food status: FED |
|
175.3 ng × h/mL |
4 mg single, intramuscular dose: 4 mg route of administration: Intramuscular experiment type: SINGLE co-administered: |
TIMIPERONE plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: UNKNOWN food status: UNKNOWN |
T1/2
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
5.906 h |
6 mg single, oral dose: 6 mg route of administration: Oral experiment type: SINGLE co-administered: |
TIMIPERONE plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: UNKNOWN food status: FED |
|
15.7 h |
4 mg single, intramuscular dose: 4 mg route of administration: Intramuscular experiment type: SINGLE co-administered: |
TIMIPERONE plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: UNKNOWN food status: UNKNOWN |
Funbound
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
5% |
TIMIPERONE plasma | Homo sapiens |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Atypical properties of several classes of antipsychotic drugs on the basis of differential induction of Fos-like immunoreactivity in the rat brain. | 2004-11-26 |
|
| Effect of hyperprolactinemia induced by pituitary grafts or castration on porphyrin content of the mouse Harderian gland. | 2001-08 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:19:13 GMT 2025
by
admin
on
Mon Mar 31 18:19:13 GMT 2025
|
| Record UNII |
626DQ7N19L
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C28197
Created by
admin on Mon Mar 31 18:19:13 GMT 2025 , Edited by admin on Mon Mar 31 18:19:13 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
2668
Created by
admin on Mon Mar 31 18:19:13 GMT 2025 , Edited by admin on Mon Mar 31 18:19:13 GMT 2025
|
PRIMARY | |||
|
3033151
Created by
admin on Mon Mar 31 18:19:13 GMT 2025 , Edited by admin on Mon Mar 31 18:19:13 GMT 2025
|
PRIMARY | |||
|
100000077222
Created by
admin on Mon Mar 31 18:19:13 GMT 2025 , Edited by admin on Mon Mar 31 18:19:13 GMT 2025
|
PRIMARY | |||
|
TIMIPERONE
Created by
admin on Mon Mar 31 18:19:13 GMT 2025 , Edited by admin on Mon Mar 31 18:19:13 GMT 2025
|
PRIMARY | |||
|
260-880-9
Created by
admin on Mon Mar 31 18:19:13 GMT 2025 , Edited by admin on Mon Mar 31 18:19:13 GMT 2025
|
PRIMARY | |||
|
4525
Created by
admin on Mon Mar 31 18:19:13 GMT 2025 , Edited by admin on Mon Mar 31 18:19:13 GMT 2025
|
PRIMARY | |||
|
C76451
Created by
admin on Mon Mar 31 18:19:13 GMT 2025 , Edited by admin on Mon Mar 31 18:19:13 GMT 2025
|
PRIMARY | |||
|
CHEMBL2107117
Created by
admin on Mon Mar 31 18:19:13 GMT 2025 , Edited by admin on Mon Mar 31 18:19:13 GMT 2025
|
PRIMARY | |||
|
57648-21-2
Created by
admin on Mon Mar 31 18:19:13 GMT 2025 , Edited by admin on Mon Mar 31 18:19:13 GMT 2025
|
PRIMARY | |||
|
626DQ7N19L
Created by
admin on Mon Mar 31 18:19:13 GMT 2025 , Edited by admin on Mon Mar 31 18:19:13 GMT 2025
|
PRIMARY | |||
|
m10870
Created by
admin on Mon Mar 31 18:19:13 GMT 2025 , Edited by admin on Mon Mar 31 18:19:13 GMT 2025
|
PRIMARY | Merck Index | ||
|
SUB11065MIG
Created by
admin on Mon Mar 31 18:19:13 GMT 2025 , Edited by admin on Mon Mar 31 18:19:13 GMT 2025
|
PRIMARY | |||
|
C024159
Created by
admin on Mon Mar 31 18:19:13 GMT 2025 , Edited by admin on Mon Mar 31 18:19:13 GMT 2025
|
PRIMARY | |||
|
DTXSID9023673
Created by
admin on Mon Mar 31 18:19:13 GMT 2025 , Edited by admin on Mon Mar 31 18:19:13 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |